SCD-PROTECT: Wearable Defibrillators Key in First Months After Heart Failure Diagnosis скачать в хорошем качестве

SCD-PROTECT: Wearable Defibrillators Key in First Months After Heart Failure Diagnosis

Marat Fudim, MD, MHS, Duke Health, highlights findings from the SCD-PROTECT registry, the largest contemporary study of wearable cardiac defibrillators in over 19,000 German patients with new-onset HFrEF post-MI or non-ischemic cardiomyopathy. He notes that sudden cardiac death risk is highest in the first months post-discharge, affecting both ischemic and non-ischemic patients, and that wearable defibrillators offer critical short-term protection while patients are on guideline-directed medical therapy. Fudim emphasizes the real-world value of standardized use and high adherence, underscoring that early events are common even in well-treated patients, and that this data may reshape clinical practice despite guideline limitations.